Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 18, 2018 - Issue 8
Submit an article Journal homepage
307
Views
4
CrossRef citations to date
0
Altmetric
Review

Cerebrolysin: a multi-target drug for recovery after stroke

Michael BraininDepartment of Neurosciences and Preventive Medicine, Danube University Krems, Krems, AustriaCorrespondence[email protected]
View further author information
Pages 681-687 | Received 30 May 2018, Accepted 11 Jul 2018, Published online: 18 Jul 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Suraj Sharma, Khadga Raj & Shamsher Singh. (2022) Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive impairment in Albino mice. Drug and Chemical Toxicology 45:6, pages 2769-2779.
Read now
Yuqian Ren, Xiaoqing Ma, Tingting Wang, Baohe Cheng, Leiming Ren, Zehua Dong & Hongling Liu. (2021) The Cerebroprotein Hydrolysate-I Plays a Neuroprotective Effect on Cerebral Ischemic Stroke by Inhibiting MEK/ERK1/2 Signaling Pathway in Rats. Neuropsychiatric Disease and Treatment 17, pages 2199-2208.
Read now
Xiaolin Wu, Yingjuan Liu, Lin Zhu, Yue Wang, Yuqian Ren, Baohe Cheng, Leiming Ren, Keli Ge & Hongyun Li. (2021) Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice. Neuropsychiatric Disease and Treatment 17, pages 2359-2368.
Read now
Fei Niu, Ke Qian, Hongyan Qi, Yumei Zhao, Yingying Jiang, Wang Jia & Ming Sun. (2020) CPCGI Reduces Gray and White Matter Injury by Upregulating Nrf2 Signaling and Suppressing Calpain Overactivation in a Rat Model of Controlled Cortical Impact. Neuropsychiatric Disease and Treatment 16, pages 1929-1941.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.